What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His primary scientific interests are in Internal medicine, Cancer research, Endocrinology, Breast cancer and Cancer.
His work on Oncology expands to the thematically related Internal medicine.
His Cancer research research includes elements of Cancer cell, Apoptosis, Cell cycle, Insulin-like growth factor 1 receptor and Growth factor receptor.
His Endocrinology study incorporates themes from Growth factor, Signal transduction, Tyrosine phosphorylation and Estrogen receptor.
The concepts of his Breast cancer study are interwoven with issues in Point mutation, Randomized controlled trial, Surgery and In vivo.
Douglas Yee has researched Cancer in several fields, including Diabetes mellitus and Clinical trial.
His most cited work include:
- Diabetes and Cancer: A consensus report (1428 citations)
- APOBEC3B is an enzymatic source of mutation in breast cancer (550 citations)
- Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins. (471 citations)
What are the main themes of his work throughout his whole career to date?
Douglas Yee focuses on Internal medicine, Breast cancer, Cancer research, Cancer and Endocrinology.
Internal medicine is closely attributed to Oncology in his work.
His research in Breast cancer intersects with topics in Immunology, Clinical trial and Chemotherapy.
His studies deal with areas such as Insulin receptor, Insulin-like growth factor 1 receptor, Growth factor and Signal transduction, Growth factor receptor as well as Cancer research.
His research on Cancer frequently links to adjacent areas such as Bioinformatics.
His Endocrinology research incorporates elements of Cell culture, Autocrine signalling, Cell growth, Cancer cell and Insulin-like growth factor-binding protein.
He most often published in these fields:
- Internal medicine (50.65%)
- Breast cancer (39.68%)
- Cancer research (37.74%)
What were the highlights of his more recent work (between 2014-2021)?
- Internal medicine (50.65%)
- Breast cancer (39.68%)
- Oncology (20.65%)
In recent papers he was focusing on the following fields of study:
Douglas Yee mainly focuses on Internal medicine, Breast cancer, Oncology, Cancer and Cancer research.
His study ties his expertise on Endocrinology together with the subject of Internal medicine.
The study incorporates disciplines such as Stage, Complete response, Clinical trial and Randomized controlled trial in addition to Breast cancer.
His Oncology research focuses on Neoadjuvant therapy and how it connects with Surgery.
His study looks at the relationship between Cancer and topics such as Cyclophosphamide, which overlap with Paclitaxel.
His Cancer research research integrates issues from Insulin receptor, Cancer cell, Receptor, Metastasis and Estrogen receptor.
Between 2014 and 2021, his most popular works were:
- Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer (291 citations)
- Adaptive Randomization of Neratinib in Early Breast Cancer (202 citations)
- Pembrolizumab plus standard neoadjuvant therapy for high-risk breast cancer (BC): Results from I-SPY 2. (134 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Douglas Yee mainly investigates Internal medicine, Breast cancer, Oncology, Cancer and Clinical trial.
His Internal medicine study combines topics in areas such as Endocrinology and Cardiology.
His study in Endocrinology is interdisciplinary in nature, drawing from both Cancer cell, PDK4 and Mutation.
His studies in Breast cancer integrate themes in fields like Stage, Randomized controlled trial and Receiver operating characteristic.
His work on Breast cancer screening as part of general Cancer research is frequently linked to Multimedia, Intervention and Health care, thereby connecting diverse disciplines of science.
Douglas Yee interconnects Cancer research, Downregulation and upregulation, Insulin-like growth factor 1 receptor, Growth factor and Signal transduction in the investigation of issues within Insulin receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
